Safety of β2-agonists: a 50-year debate closed?

Eur Respir J. 2014 Jan;43(1):6-9. doi: 10.1183/09031936.00193813.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / adverse effects*
  • Asthma / drug therapy*
  • Ethanolamines / adverse effects*
  • Formoterol Fumarate
  • Humans

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Ethanolamines
  • Formoterol Fumarate